SGMO Financial Facts
Total operating expenses: 22.03MLoss from operations: -19.21M
See Full Income Statement
Prepaid expenses: 1.47M
Accumulated other comprehensive income / (loss): 77K
See Full Balance Sheet
Sangamo Biosciences Inc. (SGMO) Earnings
|
Expand Research on SGMO
| Next EPS Date | 5/1/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -48.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/10/17 |  |
Q117 | -$0.23 | -$0.26 | +$0.03 | $3.43M | $4.25M | = |  | | Details |
| 2/28/20 | |
Q419 | $0.04 | -$0.33 | +$0.37 | $54.9M | $15.54M | N/A | | | Details |
2/10/15  |
|
Q414 | -$0.06 | -$0.09 | +$0.03 | $14.95M | $14.5M | = | | | Details |
| 8/9/17 | |
Q217 | -$0.17 | N/A | N/A | $8.3M | $3.7M | = | | | Details |
| 11/9/17 | |
Q317 | -$0.15 | -$0.19 | +$0.04 | $11.8M | $10.36M | = | | | Details |
| 5/11/20 | |
Q120 | -$0.37 | -$0.29 | -$0.08 | $13.1M | $22.74M | N/A | | | Details |
| 10/22/14 |
|
Q314 | -$0.11 | -$0.14 | +$0.03 | $12.4M | $8.27M | = | | | Details |
| 8/8/18 | |
Q218 | -$0.17 | -$0.15 | -$0.02 | $21.4M | $21.43M | N/A | | | Details |
